15:23 IST
BSE
Fund Raise
Ishita Drugs & Industries Fund Raise
Ishita Drugs & Industries Ltd submitted a NIL statement of deviation or variation under SEBI Regulation 32(1). The company confirmed it raised no funds through public, rights, or preferential issues during FY 2025-26. This routine regulatory filing maintains compliance and transparency regarding the company's capital raising activities.